Payment overview · 2025
General Payments
$59.63
4 reported records · 3 companies
Healthcare provider profile · identity verified
Clinton Washington, MD
Allopathic & Osteopathic Physicians|Family Medicine · SMITHVILLE, MS · NPI 1437163763
Verified facts
What the public records show
CMS Open Payments records show Clinton Washington, MD received $59.63 in general payments during 2025 across 4 reported records.
ABBVIE INC. accounted for 48.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lumigan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $29.07 | 48.8% | 2 | 2025 |
| Radius Health, Inc. | Unresolved — no canonical attribution shown | $15.47 | 25.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.09 | 25.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $59.63 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Tymlos Normalized: tymlos |
Drug | Radius Health, Inc. | $15.47 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $15.40 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.09 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $13.67 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $13.67 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 489 | 146 |
| Amlodipine Besylate | Amlodipine Besylate | 351 | 110 |
| Levothyroxine Sodium | Levothyroxine Sodium | 338 | 94 |
| Gabapentin | Gabapentin | 318 | 89 |
| Lisinopril | Lisinopril | 304 | 101 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 284 | 67 |
| Losartan Potassium | Losartan Potassium | 272 | 84 |
| Omeprazole | Omeprazole | 270 | 83 |
| Hydrochlorothiazide | Hydrochlorothiazide | 209 | 72 |
| Potassium Chloride | Potassium Chloride | 186 | 63 |
| Meloxicam | Meloxicam | 183 | 72 |
| Furosemide | Furosemide | 178 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 176 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 51 |
| Metformin Hcl Er | Metformin Hcl | 165 | 59 |
| Carvedilol | Carvedilol | 137 | 42 |
| Alprazolam | Alprazolam | 128 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 127 | 52 |
| Sertraline Hcl | Sertraline Hcl | 125 | 40 |
| Donepezil Hcl | Donepezil Hcl | 124 | 27 |
| Ozempic | Semaglutide | 116 | 20 |
| Famotidine | Famotidine | 106 | 31 |
| Trazodone Hcl | Trazodone Hcl | 106 | 34 |
| Ezetimibe | Ezetimibe | 104 | 34 |
| Buspirone Hcl | Buspirone Hcl | 100 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 99 | 37 |
| Eliquis | Apixaban | 96 | 22 |
| Tramadol Hcl | Tramadol Hcl | 90 | 22 |
| Farxiga | Dapagliflozin Propanediol | 82 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 14 |
| Metformin Hcl | Metformin Hcl | 77 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 76 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 76 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 74 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 73 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 23 |
| Lovastatin | Lovastatin | 72 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 66 | 13 |
| Azithromycin | Azithromycin | 64 | 48 |
| Fenofibrate | Fenofibrate Nanocrystallized | 64 | 19 |
| Montelukast Sodium | Montelukast Sodium | 63 | 23 |
| Spironolactone | Spironolactone | 61 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 57 | 15 |
| Allopurinol | Allopurinol | 54 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | 14 |
| Januvia | Sitagliptin Phosphate | 53 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 49 | 13 |
| Jardiance | Empagliflozin | 49 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 49 | 20 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 49 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 14 |
| Meclizine Hcl | Meclizine Hcl | 44 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 15 |
| Lorazepam | Lorazepam | 42 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | 12 |
| Digoxin | Digoxin | 40 | suppressed |
| Fluconazole | Fluconazole | 40 | 21 |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 39 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 12 |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 38 | 13 |
| Propranolol Hcl | Propranolol Hcl | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 29 |
| Bupropion Xl | Bupropion Hcl | 36 | 13 |
| Baclofen | Baclofen | 35 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 35 | suppressed |
| Methylprednisolone | Methylprednisolone | 34 | 25 |
| Pregabalin | Pregabalin | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 24 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 33 | 17 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 33 | 21 |
| Fenofibrate | Fenofibrate | 33 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 33 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 31 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 27 | suppressed |
| Simvastatin | Simvastatin | 27 | 11 |
| Linzess | Linaclotide | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Phenobarbital | Phenobarbital | 21 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 20 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Gvoke Pfs 1-Pack Syringe | Glucagon | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Prednisone | Prednisone | 19 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 12 |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 18 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 15 | 11 |
| Dutasteride | Dutasteride | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Tadalafil | Tadalafil | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $59.63 · 4 records | ABBVIE INC. | Cologuard Collection Kit, QULIPTA, Tymlos, UBRELVY, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error